Cargando…

High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancer

Extracellular matrix (ECM), as an important framework for tumor microenvironment, plays important roles in many critical processes, including tumor growth, invasion, immune suppression, and drug resistance. However, few biomarkers of ECM-related genes (ERGs) have been developed for prognosis predict...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xuezhou, Liu, Jing, Yang, Xuecheng, Jiao, Wei, Shen, Chengquan, Zhao, Xinzhao, Wang, Yonghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928451/ https://www.ncbi.nlm.nih.gov/pubmed/36474424 http://dx.doi.org/10.1080/15384101.2022.2154551

Ejemplares similares

High expression of GMNN predicts malignant progression and poor prognosis in ACC
por: Zhao, Xinzhao, et al.
Publicado: (2022)

Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma
por: Shen, Chengquan, et al.
Publicado: (2021)

COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer
por: Owusu-Ansah, Kwabena Gyabaah, et al.
Publicado: (2019)

Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients
por: Wan, Fangning, et al.
Publicado: (2015)

The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA
por: Shen, Chengquan, et al.
Publicado: (2020)

Overexpression of COL3A1 confers a poor prognosis in human bladder cancer identified by co-expression analysis
por: Yuan, Lushun, et al.
Publicado: (2017)

High expression COL10A1 promotes breast cancer progression and predicts poor prognosis
por: Zhou, Weijian, et al.
Publicado: (2022)

Overexpression of PTK6 predicts poor prognosis in bladder cancer patients
por: Xu, Xue-lian, et al.
Publicado: (2017)

High expression of COL10A1 is associated with poor prognosis in colorectal cancer
por: Huang, Haipeng, et al.
Publicado: (2018)

Predictions for high COL1A1 and COL10A1 expression resulting in a poor prognosis in esophageal squamous cell carcinoma by bioinformatics analyses
por: Li, Yang, et al.
Publicado: (2020)

N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer
por: Zhang, Yuying, et al.
Publicado: (2021)

Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancer
por: Shen, Chengquan, et al.
Publicado: (2020)

Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer
por: Shen, Chengquan, et al.
Publicado: (2020)

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma
por: Li, Huihuang, et al.
Publicado: (2022)

TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma
por: Kou, Fan, et al.
Publicado: (2020)

Col. Martin, on Destroying the Stone in the Bladder
Publicado: (1799)

COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma
por: Wang, Hongbo, et al.
Publicado: (2021)

Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer
por: Hui, Pengyu, et al.
Publicado: (2023)

COL3A1 Overexpression Associates with Poor Prognosis and Cisplatin Resistance in Lung Cancer
por: Wang, Lihuai, et al.
Publicado: (2022)

Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
por: Wang, Yejinpeng, et al.
Publicado: (2020)

High Expression of COL17A1 Predicts Poor Prognosis and Promotes the Tumor Progression via NF-κB Pathway in Pancreatic Adenocarcinoma
por: Mao, Feiyu, et al.
Publicado: (2020)

Robust Prediction of Prognosis and Immunotherapy Response for Bladder Cancer through Machine Learning Algorithm
por: Hu, Shanshan, et al.
Publicado: (2022)

Versican enrichment predicts poor prognosis and response to adjuvant therapy and immunotherapy in gastric cancer
por: Song, Junquan, et al.
Publicado: (2022)

Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma
por: Zhou, Xincheng, et al.
Publicado: (2022)

Low Expression of Keratin17 is Related to Poor Prognosis in Bladder Cancer
por: Wu, Jiacheng, et al.
Publicado: (2021)

Enhanced Expression of CNTD2/CCNP Predicts Poor Prognosis in Bladder Cancer Based on the GSE13507
por: Gong, Mancheng, et al.
Publicado: (2021)

Low expression of IL6R predicts poor prognosis for lung adenocarcinoma
por: Sun, Gaofeng, et al.
Publicado: (2021)

Classification of Muscle Invasive Bladder Cancer to Predict Prognosis of Patients Treated with Immunotherapy
por: Wang, Zhifeng, et al.
Publicado: (2022)

Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer
por: Yao, Zhihao, et al.
Publicado: (2022)

Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients
por: Shen, Chong, et al.
Publicado: (2020)

CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer
por: Zhang, Xiao‐Guang, et al.
Publicado: (2018)

Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer
por: Wang, Xin, et al.
Publicado: (2017)

Glandular differentiation in pT1 urothelial carcinoma of bladder predicts poor prognosis
por: Zhao, Guobin, et al.
Publicado: (2019)

Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer
por: Guo, Mengjie, et al.
Publicado: (2018)

Mutations in gliclazide‐associated genes may predict poor bladder cancer prognosis
por: Wen, Weiheng, et al.
Publicado: (2019)

Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma
por: Zhong, Yonglong, et al.
Publicado: (2015)

ceRNA network-regulated COL1A2 high expression correlates with poor prognosis and immune infiltration in colon adenocarcinoma
por: Yuan, Xia, et al.
Publicado: (2023)

High expression of HEF1 is associated with poor prognosis in urinary bladder carcinoma
por: Zhang, Qi, et al.
Publicado: (2014)

Increased expression of miR-222 is associated with poor prognosis in bladder cancer
por: Zhang, Dong-qing, et al.
Publicado: (2014)

High expression of ABCF1 is an independent predictor of poor prognosis in bladder cancer
por: Fan, JiaWen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rndc1nbehm016l4vvp584pqukm